---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-23-000048"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2023-09-26T23:59:59+00:00"
generated_at: "2026-06-10T08:38:09.608039+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pacira CEO David Stack to retire; board initiates search for successor

## Summary
- Stack will remain as CEO until successor is appointed, then serve as consultant through August 2025.
- Entitled to base salary through Sept 1, 2024; continues equity vesting and bonus eligibility for 2023-2024.
- Board retains Klein Hersh International to lead comprehensive CEO search.
- Transition agreement includes non-disparagement, cooperation, indemnification, and consulting fee of $20k/month for up to 15 hours.
- Press release issued September 26, 2023; retirement effective upon appointment of new CEO.

## SEC filing metadata
- accession: 0001396814-23-000048
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2023-09-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/0001396814-23-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/pcrx-20230920.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-23-000048
- JSON: https://secwatch.observer/filing/0001396814-23-000048.json
- Plain text: https://secwatch.observer/filing/0001396814-23-000048.txt

## Key facts
- Executive change
  David Stack departed as Chief Executive Officer at Pacira BioSciences, Inc..
  - Action: retire
  - Role: Chief Executive Officer
  source text: David Stack informed the Board of Directors (the "Board") of Pacira BioSciences, Inc. (the "Company") that he intends to retire as Chief Executive Officer of the Company and as a member of the Board effective immediately following the appointment of his successor as Chief Executive Officer in order to ensure a smooth transition of leadership.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681423000048/0001396814-23-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.